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1. Introduction 
Implantation is the final frontier to embryogenesis and successful pregnancy. Over the past 
three decades, there have been tremendous advances in the understanding of human 
embryo development. Since the advent of In Vitro Fertilization, the embryo has been readily 
available to study outside the body. Indeed, the study has led to much advancement in 
embryonic stem cell derivation. Unfortunately, it is not so easy to evaluate the steps of 
implantation since the uterus cannot be accessed by most research tools. This has limited 
our understanding of early implantation. Both the physiological and pathological 
mechanisms of implantation occur largely unseen. The heterogeneity of these processes 
between species also limits our ability to develop appropriate animal models to study. In 
humans, there is a precise coordinated timeline in which pregnancy can occur in the uterus, 
the so called “window of implantation”. However, in many cases implantation does not 
occur despite optimal timing and embryo quality. It is very frustrating to both a patient and 
her clinician to transfer a beautiful embryo into a prepared uterus only to have it fail to 
implant. This chapter will review the mechanisms of human embryo implantation and 
discuss some reasons why it fails to occur. 
2. Phases of human embryo implantation 
The human embryo enters the uterine cavity approximately 4 to 5 days post fertilization. 
After passing down the fallopian tube or an embryo transfer catheter, the embryo is 
moved within the uterine lumen by rhythmic myometrial contractions until it can 
physically attach itself to the endometrial epithelium. It hatches from the zona pellucida 
within 1 to 2 days after entering the cavity thereby exposing the trophoblastic cells of the 
trophectoderm to the uterine epithelium. Implantation occurs 6 or 7 days after 
fertilization. During implantation and placentation, a human embryo must attach itself to 
the uterus under conditions of shear stress. The embryo is rolling about within a mucus 
rich environment between the opposing surfaces of the endometrial walls of the uterus. 
This interactive process is a complex series of events that can be divided into three distinct 
steps: apposition, attachment and invasion (Norwitz et al., 2001). 
2.1 Apposition 
Once the human blastocyst hatches from the zona pellucida, the free-floating sphere of cells 
must orient itself as it approaches the endometrial surface and form an initial adhesion 
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(apposition) before it can firmly attach and begin the process of invasion. The apposition 
step is a transient and dynamic process whereby the embryo “tethers” itself to the 
endometrial surface. Uterine contractions and mucin secretion within the uterine cavity 
propel the blastocyst around the cavity. Despite these fluid dynamics which creates shear 
stress, the embryo is able to approach the wall, roll around to right itself so that the 
trophectoderm overlying the inner cell mass apposes to the endometrial surface. During this 
apposition phase, there is a dialogue between the floating blastocyst and endometrium 
using soluble mediators such as cytokines and chemokines acting in a bidirectional fashion 
to guide the blastocyst onto a 3-dimensional “docking” structure. The hormone-regulated 
pinopodes at the endometrial surface have been shown to mark the timing and appearance 
of optimal endometrial receptivity (Bentin-Ley et al., 2000).  
Chemokines such as IL-8, RANTES, or MCP-1 are secreted locally by both the endometrium 
and blastocyst during the implantation window during the apposition phase. The L-selectin 
system, in particular, has been shown to be critically important during the blastocyst 
apposition phase (Genbacev et al., 2003). Selectins are lectin-like glycoproteins that include 
E-, L- and P-selectin, all of which were originally thought to be expressed exclusively by 
hemangioblast descendents. E-selectin is expressed on activated endothelial cells, P-selectin 
is expressed on the surfaces of activated platelets and endothelial cells and L-selectin is 
expressed on lymphocytes. Initial interest in the selectin system came because the 
implantation process bears some similarity to leukocyte transmigration across the blood 
vessel wall. Similar to a rolling blastocyst, the selectin adhesion systems allow leukocytes to 
tether and roll on the endothelial surface before invading into the interstitium. Leukocytes 
use specialized mechanisms, which involve the L-selectin adhesion system, to extravasate 
from flowing blood, under shear stress, into the endothelial wall. These specialized 
mechanisms in the vasculature enable cell adhesion to occur under shear flow. Interactions 
between leukocytes and endothelium are mediated by carbohydrate-binding proteins 
(selectins) that recognize specific oligosaccharide structures as their ligands. These interactions 
allow leukocytes to slow their passage on the endothelial surface (Alon & Feigelson, 2002). 
This step is followed by integrin activation which enable leukocytes to form a firm adhesion 
with the vascular endothelial surface and, subsequently, to transmigrate into tissues (Alon & 
Feigelson, 2002 and McEver, 2002). Selectins on the cell surface initiate tethering to their 
complementary ligands on specialized endothelial cells along the vascular wall until they 
become firmly attached (McEver, 2002). These lectin-like molecules recognize specific 
oligosaccharide structures carried on some glycoproteins including PSGL-1, CD34, GlyCAM-1, 
MAdCAM-1, podocalyxin and endoglycan. They are made up of at least 30% carbohydrates 
and bind to mucin oligosaccharide ligands on the endothelium. These types of interactions 
have rapid and reversible properties such that traveling leukocytes slow down, tether, release 
and roll on the epithelial cell surface until finally attaching at the site of extravasation. Once 
arrested, integrin activation triggers stable adhesion (shear-resistant) and subsequent 
transmigration through the vascular endothelium. 
At morphological level, there are parallels between leukocyte extravasation from the 
vasculature and attachment of embryo to the uterine wall since both types of adhesion occur 
under shear flow and are followed by integrin activation. Genbacev et al. (2003) have shown 
that the L-selectin adhesion system plays a crucial role during an initial step of blastocyst 
implantation. Hatched blastocyst expresses L-selectin and uses this molecule to mediate its 
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attachment to the luminal epithelial surface via its carbohydrate ligands, MECA-79 and 
related epitopes. Two different in vitro models illustrating L-selectin mediating adhesion 
were used to confirm the in-situ observations. In the first model, beads coated with synthetic 
L-selectin carbohydrate ligands were overlaid on placental chorionic villous explants under 
shear stress. It was shown the beads bound to cell column cytotrophoblasts (CTBs) on the 
explants and the binding was blocked by antibody to L-selectin. Additional 
immunolocalization experiment confirmed that the CTBs did express L-selectin. In the 
second model, isolated CTBs were overlaid on endometrial tissue sections under shear 
stress. It was shown that CTBs bound to epithelial surface of the endometrium tissues that 
were obtained during the luteal phase and did not bind to those that were obtained during 
the follicular phase. Again, the binding was blocked by anti-L-selectin antibody. Concurring 
with these observations, immunolocalization study of endometrial tissue demonstrated that 
the L-selectin carbohydrate ligand MECA-79 was upregulated from the day of ovulation to a 
peak 6 days post ovulation at the middle of the implantation window. It was negative 
throughout the follicular phase and remained negative if ovulation did not occur. Carson et 
al (2006) have shown that MUC-1, a transmembrane mucin glycoprotein expressed at the 
apical surface of the uterine epithelia, likely serves as a scaffold for these L- selectin 
carbohydrate ligands. Together, these studies suggests that the human embryo uses a 
mechanism well studied in leukocytes to mediate rolling and tethering onto the endometrial 
wall prior to firm adhesion when integrins begin their crucial role.  
2.2 Embryo attachment 
Shortly after the apposition step, integrin-dependent adhesion and attachment occurs. 
This receptor mediated event allows the blastocyst to attach firmly to the uterine wall and 
trophoblasts transmigrate across the luminal epithelium, burying the embryo beneath the 
uterine wall. Integrins are a family of cell adhesion molecules present on the plasma 
membrane as heterodimeric ǂ and ǃ glycoprotein subunits. These cell surface receptors on 
both the trophoblasts and the endometrium are involved at multiple functional levels 
during implantation. The trophoblast integrins have been shown to mediate cell-cell and 
cell-matrix interaction in trophoblast attachment, migration, differentiation and apoptosis. 
On the endometrial surface, most of the integrins serve housekeeping roles, but there are 
three heterodimers whose expression marks the boundaries of the implantation window 
(Lessey, 2002). The endometrial integrin ǂ1ǃ1 is expressed during the full span of the 
implantation window from ovulation to the late luteal phase. The expression of ǂ4ǃ1 
begins with ovulation, but ceases as the window closes on cycle day 24. The endometrial 
integrin ǂvǃ3 appears on the apical surface of the endometrial epithelium on cycle day 19 
to 20, the opening of the implantation window and diminishes quickly through the next 
week. Its ligand, osteopontin is found concurrent with ǂvǃ3 and might play a role in 
endometrial or embryo signaling, facilitating embryo attachment to the apical surface 
prior to invasion.  
Absence of ǂvǃ3 expression during the window of implantation has been reported with 
luteal phase deficiency and in some women with endometriosis, unexplained infertility and 
hydrosalpinges. This loss of normal integrin expression is thought to lead to implantation 
failure. Integrin knockout studies found that ǃ1 null mice embryos develop normally to the 
blastocyst stage but fail to implant (Stephens et al., 1995). The human embryo regulates 
www.intechopen.com
 Advances in Embryo Transfer 196 
these integrins in the human endometrium at the protein level in the apposition phase 
(Simon et al., 1997). Therefore, after the human blastocyst tethers to and breaks through the 
glycocalix barrier, it then induces by paracrine crosstalk a favorable epithelial integrin 
pattern for its firm attachment. 
2.3 Trophoblast Invasion 
The final phase of implantation is invasion which permits the creation of the hemochorial 
placenta. The term invasiveness implies the ability of cells to cross anatomic barriers. The first 
barrier is the layer of endometrial epithelial cells upon which the trophoblasts are attached. 
Immediately beneath the epithelial layer of cells is a specialized type of matrix called the 
basement membrane, a thin continuous layer composed mainly of type IV collagen. The 
basement membrane functions as an anchor for surface epithelium and a separating layer by 
ensheathing blood vessels, muscle cells and nervous tissue. Beyond the basement membrane 
lies a highly variable matrix, called the interstitial stroma which contains other tissue cells, 
vessels and lymphatic channels. Since the blastocyst is too large to squeeze through the 
epithelial layer, the attached trophoblasts use paracrine activity to induce an apoptotic reaction 
in the underlying endometrial epithelial cells (Galan et al., 2000). 
To achieve successful invasion, trophoblasts then differentiate in a tightly regulated manner 
producing anchoring cytotrophoblasts and highly secretory synciotrophoblasts that 
degrades the extracellular matrix with several proteases. The expression of matrix 
metalloprotease – 9 coincides with the peak invasive potential of trophoblasts. By the 10th 
day after fertilization, the blastocyst is completely embedded in the stromal tissue of the 
endometrium with the epithelium regrown over to cover the site of implantation. 
Eventually, the cytotrophoblasts invade the entire endometrium, the uterine vasculature 
and into the inner third of the myometrium. The access to the uterine vessels creates the 
lacunar networks comprising the uteroplacental circulation which places the placental 
trophoblasts in direct contact with maternal blood. The placenta then serves its vital role as 
the transfer organ between mother and fetus for nutrients, gas and waste products, 
hormones and growth factors, among others. 
Improper invasion can lead to compromised placental development and complications of 
pregnancy. Where there is excessive invasion, a placenta may attach onto the myometrium 
(accreta), into the myometrium (increta) and completely through the myometrium 
(percreta). Each of these is associated with higher risks of hemorrhage, operative delivery 
and hysterectomy. If invasion is too shallow, it may lead to intrauterine growth restriction 
and/or preeclampsia (Zhou et al., 1997). 
3. Optimizing embryonic implantation 
For couples who suffer from infertility, assisted reproductive techniques have proven to be 
the most effective in overcoming the majority of barriers. The effectiveness of in vitro 
fertilization (IVF) is achieved by the ability to bypass certain barriers such as low sperm 
counts or tubal dysfunction and to choose the most competent embryo to be placed in the 
uterine cavity at the best time. The factors that limit IVF success can be generally be distilled 
down to the health of the embryo versus the health of the endometrium, or in essence an 
evaluation of the seed versus the soil.  
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3.1 Embryo (seed) 
In the past decade, there have been tremendous strides into the study of embryonic 
competence, or the assessment of what constitutes the embryo with the highest potential to 
implant and create a baby. Historically, the most common means of assessment is based on 
morphological observation of an embryo’s development in optimal culture conditions. 
Although this has steadily improved the ability to select the embryos with the highest 
reproductive potential, thereby increasing pregnancy rates while decreasing multiple 
gestations, the vast majority of embryos fail to implant. These failures and frustrations have 
led to the expansion of tools and means to better evaluate the embryo. Metabolomics and 
proteomics are fields of study into the culture conditions of the embryos looking for soluble 
markers of improved embryo health. Unfortunately, assessment by morphology and/or 
culture conditions are not enough since aneuploidy contributes to the majority of unhealthy 
embryos. Genomics has much promise since chromosomal abnormalities represent a 
substantial prevalence of reproductive waste (Hassold, 2007). Clinically, this is 
demonstrated by a woman’s age with reduced fecundity, greater miscarriage rates and 
higher numbers of births with aneuploidy. Indeed, in clinical practice, the age of the oocyte 
is the single most important variable influencing the outcome of assisted reproduction. 
This has led to preimplantation genetic diagnosis (PGD) or assessment to determine the 
chromosomal constitution before embryo transfer. Initially, polar body biopsy and 
blastomere biopsies from day 3 embryos were assessed with fluorescent-in-situ 
hybridization (FISH) for evaluation of a select number of chromosomes. A full discussion of 
PGD assessment is outside the scope of this chapter but briefly, because of the limitations of 
FISH, the assay techniques and timing of biopsy have continued to evolve into the 
development of comprehensive chromosomal screening platforms (Schoolcraft et al., 2011). 
Several advancements have improved the ability to correctly determine the reproductive 
potential of a single blastocyst. Combining the technique of trophectoderm biopsy, 
vitrification and 23 chromosome assessment by single-nucleotide polymorphism (SNP)-
based microarray screening has shown promising data at markedly improving the 
implantation rate to over 60% and reducing the miscarriage rate. This represents an 
improvement in implantation rates simply by selecting the most reproductively competent 
seed. However, it is sobering to note that an implantation rate as high as 60% still means 
that 40% of the most highly selected embryos with a normal chromosome complement still 
fail to implant. Hence, the health of the seed is not the only component. Undoubtedly, 
further answers will come from the endometrial side of the equation. 
3.2 Endometrium (soil) 
Prior to implantation the endometrium undergoes extensive hormonal preparation to produce 
an epithelium capable of implantation. The development of the receptive endometrium is 
dependent on estrogen inducing rapid proliferation of the tissue followed by progesterone 
inducing a secretory pattern. The importance of these steroids cannot be understated as 
pregnancy cannot occur without them. Their effect is to organize the endometrium or “soil” 
appropriately so that local cytokines and chemokines can direct the activities in implantation. 
If the soil is ill prepared by improper hormonal signaling, the following events are much less 
likely to occur. When optimally primed, the endometrium becomes the most receptive. During 
the menstrual cycle between cycle days 20-24, or 6 – 10 days post ovulation, the endometrium 
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becomes receptive to implantation during a well defined span of time, the so called “window 
of implantation”. Outside this window, the endometrium is refractory to implantation. It is as 
if there are resistant factors that inhibit implantation. In fact, an embryo has a better chance of 
implanting in a fallopian tube or on the peritoneal surface then it does on the unreceptive 
endometrium. The acquisition of receptivity is a regulated process. Certain disorders that can 
lead to infertility may be either the absence of receptive molecules or the presence of resistant 
molecules that inhibit implantation. It has been suggested that MUC1 may act as an anti-
adhesion molecule during embryo attachment in the mouse (Surveyor et al., 1995). One theory 
proposed is that MUC1 acts like bare branches on a Christmas tree that are resistant until 
adorned with ornaments that serve as ligands to embryonic receptors (see fig. 1). Since MUC1 
acts as a scaffold to ligands of L-selectin, it is possible that a disruption of this glycoprotein 
complex may lead to failed implantation. 
 
Fig. 1. Model of initial apposition of hatched blastocyst to uterine luminal epithelium 
Unlike soil which takes a relatively passive role to the active functions of a seed, the 
endometrium must engage equally to become receptive and permit the peaceful invasion of 
a foreign group of cells. The critical component creating this receptivity is the dialogue that 
occurs between the endometrium and the attaching blastocyst. The endometrium prepares 
its “landing zones” at the same time a hatching blastocyst prepares it’s “tethering tentacles” 
as it moves about the lumen. As the two appose one another the receptive endometrium 
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actively participates in the implantation process through paracrine bidirectional cross-talk. 
Using the analogy above, the approaching embryo instructs the tree branches (i.e. 
endometrium) to self decorate with appropriate ornaments or ligands for tethering by the L-
selectin molecules expressed on the exposed trophectoderm. One could hypothesize that 
infertile patients who suffer from repeated implantation failure would either lack or have 
diminished ligands on their endometrium during the window of implantation. 
4. Study into the failure of implantation 
Given the many and varied causes of infertility and early pregnancy loss, we 
hypothesized that defects in the selectin adhesion system could account for a portion of 
unexplained reproductive failures. In practice, there are subgroups of women undergoing 
in vitro fertilization who repeatedly fail to implant despite the transfer of top quality 
embryos. Our goal was to assess whether the absence of the L-selectin ligand MECA-79 on 
the endometrium occurs more frequently in patients with repeated implantation failure 
(RIF), and if the lack of the endometrial L-selectin ligand correlates with unsuccessful 
implantation.  
4.1 Study design 
We compared the presence of endometrial L-selectin ligand in a fertile population to a 
subgroup of patients with a history of repeated implantation failures. The subjects 
underwent endometrial biopsies during the mid luteal phase (e.g. implantation window) of 
an ovulation induction cycle. Those patients with implantation failure continued their 
pursuits of pregnancy through further treatments. The outcome of each patient was 
followed and tabulated according to whether they did or did not have the L-selectin ligand 
recognized by immunostaining with the antibody MECA-79. 
4.2 Patient selection 
Control subjects were healthy young women with proven fertility who were serving as 
anonymous ovum donors. Twenty RIF patients were recruited at the Nevada Center for 
Reproductive Medicine. Approval for this research was obtained from the Renown Medical 
Center Institutional Review Board of the Committee for Human Rights in Research. Patients 
were recruited if they had at least two unsuccessful in-vitro fertilization cycles due to 
implantation failure. The diagnosis of implantation failure was made if no implantation 
occurred despite the transfer of top-quality embryos into a normal appearing endometrial 
cavity. The embryo morphology was scored according to criteria by Veeck (Veeck, 1999). 
Only patients who had 6-8 cell stage embryos, grade 1 and 2 transferred were included. The 
uterine cavity was assessed pre-cycle by sonohysterography and in cycle by transvaginal 
sonographic evaluation of the endometrial thickness and appearance. Only patients with an 
endometrial thickness greater than 7 mm and a trilaminar appearance were included. 
4.3 Endometrial biopsy 
Informed consent was obtained from all patients using an IRB protocol that was approved by 
the Renown Medical Center Committee on Human Research. The phase of menstrual cycle 
was confirmed by either a controlled stimulation cycle or a natural cycle monitoring. The 
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stimulation comprised 14 days of estradiol (estrace 2 mg orally bid), followed by micronized 
progesterone (prometrium 200 mg orally bid) plus estradiol (estrace 2 mg orally qd). In the 
natural cycles ovulation was confirmed by both a late follicular ultrasound and LH 
monitoring. An endometrial biopsy was obtained on day 6 of progesterone or the 7th day post 
LH surge by advancing a Unimar pipelle to the fundus, creating negative pressure and pulling 
the catheter out in a spiral fashion. The tissue was immediately fixed in 3% paraformaldehyde 
for 24 hrs. It was rinsed three times in PBS, infiltrated with 5 to 15% sucrose followed by OCT 
compound and frozen in liquid nitrogen. The tissue was sectioned (5 μm) using a 
cryomicrotome (Leica Microsystems, Bannockvurn, IL) for immunolocalization. 
4.4 Endometrial dating 
The morphology of the endometrial biopsies was scored according the dating criteria of 
Noyes by an experienced histologist (Noyes, 1950). The histologist was blinded to the 
patient history, including the cycle day of endometrial biopsy. 
4.5 Immunohistochemistry  
Rat monoclonal antibodies that recognize L-selectin ligand, MECA-79, were from BD 
Biosciences, San Jose, CA. The MECA-79 antibody recognizes a high-affinity L-selectin 
ligand carbohydrate epitope containing SO3 → 6GlcNAc (Yeh, 2001). The primary antibody 
was added at a concentration of 5 μg/μl. After the specimens were incubated at 4 oC 
overnight, they were washed three times in PBS and incubated with goat FITC-conjugated 
anti-rat IgM (Jackson ImmunoResearch Laboratories). As controls, an irrelevant rat IgM 
antibody (anti-KLH, eBioscience) or PBS was substituted for primary antibody. Staining was 
evaluated by using a Zeiss Axiophot fluorescence microscope. 
4.6 Results 
First we tested the expression of MECA-79 in the endometrial biopsies from control group 
that consisted of 20 healthy women who were proven to be fertile. All biopsy specimens had 
morphological characteristics of mid-luteal phase endometrium. The immunostaining with 
MECA-79 antibody revealed that this L-selectin ligand was present in all samples from the 
control group and that positive immunostaining was associated with the surface of the 
luminal and glandular epithelium.  
Interestingly, one control patient who initially stained negative for MECA-79 was found to 
be out of phase during a natural cycle. Later we discovered she had not ovulated. She was 
placed on a controlled stimulation cycle and subsequently stained positive at the mid-luteal 
phase. The group of RIF patients was very heterogeneous. The immunostaining with 
MECA-79 was positive in 15 out of 20 specimens (i.e., in 75% of examined biopsies – see 
Figure 2). Of these 15 positive specimens, four exhibited weak or patchy staining and eleven 
were normal. All five MECA-79 negative samples were associated with severe uterine 
anomalies, including congenital anomalies (i.e. unicornuate uterus), asherman’s syndrome, 
adenomyosis and multiple myomectomies. None of these patients became pregnant after an 
average of five separate attempts of embryo transfer (see Table 1). Out of 15 patients with 
MECA-79 positive biopsies, ten became pregnant and 5 quit treatments after an average of 
one more transfer following the biopsy.  
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Fig. 2. Presence of L-selectin ligand MECA-79 immunostaining among patients 
Of those that continued, the majority became pregnant over an average of two more 
transfers (see Table 2). Those patients that were positive for the ligand, but did not conceive 
stopped their treatments an average of 1.5 cycles sooner than those that did get pregnant 
(2.8 vs. 4.3 cycles respectively). There were no complications with the pregnancies to date.  
L-Selectin 
Ligand 
(N) 
Age 
(SD) 
Uterine History 
IVF 
History 
(no. of 
cycles) 
Implantation 
Rate 
(pregnancies / 
no. embryos) 
Absent 
(5) 
39.0 
(1.67) 
Unicornuate (2) 
Asherman’s syndrome 
Adenomyosis 
Many myomectomies 
25/5 (5) 0/72 
Patchy 
(4) 
34.7 
(4.43) 
Normal (1) 
Hydrosalpingectomy(2) 
Postpartum curettage 
17/4 (4.25) 3/47 (15.7%) 
Normal 
(11) 
40.1 
(6.73) 
Normal (6) 
Myomectomy (2) 
Mural myomas (2) 
Uterine septoplasty 
40/11 (3.6) 11/76 (14.5%) 
Table 1. Summary of Patients with Repeated Implantation Failure 
The results of this pilot study have some important implications. First, the lack of expression 
of L-selectin ligand MECA-79 in the mid-luteal endometrial biopsy specimen in this group 
of patients was indicative of a very low or no chance of pregnancy. The predictive value is 
100% with a sensitivity of 50% and specificity of 100% (see Table 3). Undoubtedly, the 
sensitivity would improve if the patients that quit treatments had persisted and become 
0
5
10
15
20
Fertile Group Reprod Failure
Normal Patchy Absent
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pregnant. Second, patients with a positive MECA-79, that had failed two good prognosis 
cycles, had about 32% chance per cycle to achieve pregnancy subsequently. Third, in 8 
patients with normal uterus and positive immunostaining with MECA-79 the probability of 
pregnancy was higher than 85% cumulatively, or 53.8% (7/13) per cycle. The implantation 
rate of those that became pregnant, however, was only 12% overall which is less than one 
third the rate seen for all patients at the treatment center. Regardless of the presence of the 
L-selectin ligand, these patients clearly represent a sub-fertile group. 
Patients 
L-selectin 
ligand 
Implantation 
Normal 
Uterus 
Implantation 
Rate (%) 
Mean 
Number 
of Cycles 
5 Absent None 0/5 0/72 embryos 5 
10 Present 10 7/10 
14/116 (12.1%) 
--after 
endometrial 
biopsy 
14/57(25%) 
4.3 
5 Present None 1/5 0/37 2.8 
Table 2. L-selectin ligand and outcome in RIF patients 
L-
Selectin 
Ligand 
Not 
Pregnant 
Pregnant 
Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
# 
subsequent 
cycles 
Pregnancy 
per cycle 
(%) 
Absent 5 0 100%  15 0/15 
Present 5 30  86% 31 
10/31 
(32.2) 
Table 3. Predictive value of L-selectin ligand absence to the lack of a subsequent pregnancy 
(screening test performed after at least two failed cycles) 
4.7 Discussion 
The apical surface of the endometrium contains key elements for the initiation of molecular 
interactions to capture the human blastocyst. The endometrium becomes hormonally 
primed through the menstrual cycle to create a period of optimal receptivity to successful 
embryonic implantation. This “window of implantation” occurs between days 20 to 24. 
Outside this window, the endometrium is resistant to embryo attachment (Navot, 1991). Lai, 
et. al described the expression of L-selectin ligand throughout the natural menstrual cycle 
(Lai, 2005) and controlled ovarian stimulation cycle (Lai, 2006). Its expression increased from 
the periovulatory interval to the mid-secretory phase. Peak immunostaining for L-selectin 
ligand was seen at the early to midsecretory interval on the luminal surface which coincides 
with the window of implantation. Interestly, a reduction in expression was seen in subjects 
who received ovulation induction medication. Vlahos, et. al found that progesterone 
supplementation enhances L-selectin ligand expression in the luteal phase following 
controlled ovarian stimulation (Vlahos, 2006). Preliminary work by Khan et al (Khan, 2005) 
found that N-acetylglucosamine-6-O-sulfotransferase (GlcNAc-6-OST), the gene responsible 
for high affinity L-selectin ligand epitope production, is regulated by estrogen and 
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progesterone. Estrogen up regulates the gene, while progesterone amplifies this action. 
Progesterone alone however will suppress GlcNAc -6-OST expression, presumably 
rendering the endometrium non-receptive. 
In our study group, those patients who lacked the ligand all had high risk histories for 
uterine defects. Iatrogenic causes include curettage and myomectomy while natural states 
like a congenital anomaly can also give rise to endometrial defects. Clearly, not all patients 
with such histories fail to achieve pregnancy, but perhaps the L-selectin ligand MECA-79 
may act as a marker for the extent of injury or anomaly prior to attempts at pregnancy in 
high risk groups.  
There could be other disease states that affect the expression of L-selectin ligand. Lessey et al 
described aberrant integrin expression in the endometrium of women with endometriosis 
(Lessey, 1994). Similarly, Kao et al found the gene, GlcNAc -6-OST, is down-regulated in 
patients with endometriosis (Kao, 2003). Mak et al found androgens suppress the gene 
expression which may play a role in poorer reproductive outcomes among patients with 
polycystic ovarian syndrome (Mak, 2005).  
Shamonki et al correlated L-selectin ligand expression with the pregnancy rate in 
subsequent donor egg cycles (Shamonki, 2006). They demonstrated significantly higher 
immunohistochemical reactivity for the L-selectin ligand at the apex of endometrial surface 
epithelium obtained during mock cycle from donor egg recipients who subsequently 
conceived compared to those who did not. They scored the intensity of staining and 
correlated it to pregnancy rate, rather than the presence or absence as we have done. The 
study further supports our finding that L-selectin plays a role in implantation not only by its 
presence but also by its degree. 
We demonstrated that the absence of L-selectin ligand in patients with multiple failed 
implantation cycles will continue to fail further attempts at implantation. Those who have 
failed but test positive for the L-selectin ligand, have a very good prognosis on subsequent 
trials of implantation despite having other unknown contributors to their subfertility. 
5. Conclusion 
Implantation of the human embryo is complex interaction between the endometrium and 
the mobile blastocyst. It must occur within a relatively narrow time frame under 
conditions of a primed receptive surface epithelium and a morphologically changing 
trophectoderm. Mechanically, the movement of the blastocyst must be arrested in order 
for attachment and then invasion can occur. The L-selectin ligand adhesion system is 
becoming more convincingly believed to play a major role in mediating initial embryonic 
apposition. By loose tethering, the blastocyst is able to attach despite the shear forces 
within the uterine lumen and orient itself for stable attachment. Once anchored, a cascade 
of events unfolds allowing the embryo to burrow into the endometrial wall and establish 
a hemochorial placenta. 
Dysfunction in either the blastocyst or the endometrium can limit the implantation 
efficiency. Many studies into embryo reproductive competence have demonstrated that 
improved selection of the embryo can drastically improve the implantation rate. While the 
endometrial side of the equation is more challenging to study, we are uncovering areas 
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where proper preparation and determination of a receptive endometrium is improving 
outcomes. At each phase along the implantation process, certain disease states have been 
shown to disrupt the delicate dialogue required for implantation. Regarding the apposition 
step, the L-selectin ligand may be used as a marker for implantation efficiency. Clinically, in 
high risk groups, one could biopsy a patient and potentially prevent many futile attempts of 
costly treatments if the ligand is absent. This would provide the patient with important 
information as to why she is unable to become pregnant and open options such as 
gestational surrogacy to help her to become a mother. Beyond apposition, defects that 
disrupt integrin expression have been shown in disease states such as endometriosis and 
hydrosalpinges. Treatment of these defects have improved outcomes. Finally, the invasion 
of cytotrophoblasts to the proper depth of the uterus is critical in determining the outcome 
of pregnancy. Excessive invasion leads to placenta accreta, while inadequate invasion has 
been implicated in the pathophysiology of preeclampsia, the leading cause of maternal 
death in the industrialized world. 
Normal implantation is crucial for successful pregnancy. For the infertile couple and their 
treating physician, a better understanding of the processes of implantation will enable better 
diagnosis and treatments to overcome the reasons why they cannot have a healthy child. 
Together, by selecting of the healthiest embryo and establishing the most receptive 
endometrium we can increase implantation efficiency. Future research into markers of 
endometrial receptivity will allow clinicians to define the optimal environment in which to 
transfer the best embryos, thereby improving pregnancy rates and decreasing complications 
such as multiple pregnancies, miscarriages and ultimately conditions that compromise the 
healthy intrauterine development of baby. 
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